Senior Counsel, Drug Pricing Policy & Litigation

BioSpace; Washington (District of Columbia); On-site; USD 190,000 - 240,000; Full time

Job summary

Sanofi Inc. seeks a senior Assistant General Counsel to shape policy, strategy and litigation across U.S. drug pricing and government programs. You will partner with North America GC, litigation, policy, and communications to define internal positions and advocacy.

The role requires extensive experience in complex litigation, strategic thinking, and the ability to translate legal analysis into practical policy outcomes that advance Sanofi’s objectives and patient access.

Qualifications

• J.D. from an ABA-accredited law school and active bar membership.
• Minimum 8 years of experience as a practicing attorney, including complex litigation.
• Ability to master complex subject matter quickly and exercise sound judgment.
• Strong executive presence and communication skills to influence senior leaders.
• Collaborative, cross-functional partner across legal, policy, and business functions.

Responsibilities

• Define internal legal positions and advocacy strategy across drug pricing and policy.
• Collaborate with senior leaders to shape environment-shaping strategy.
• Monitor federal/state developments and translate analysis into recommendations.
• Lead cross-functional initiatives on 340B program implementation.
• Advise on litigation risk and policy program design choices.

Skills

Policy & strategy thinking

Executive presence

Strategic collaboration

Complex litigation

Legal analysis to advocacy

Education

J.D. from ABA-accredited law school

Job description

Sanofi Inc. seeks a senior Assistant General Counsel to shape policy, strategy and litigation across U.S. drug pricing and government programs. You will partner with North America GC, litigation, policy, and communications to define internal positions and advocacy.

The role requires extensive experience in complex litigation, strategic thinking, and the ability to translate legal analysis into practical policy outcomes that advance Sanofi’s objectives and patient access.